Haemonetics (HAE) News Today → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free HAE Stock Alerts $95.73 +0.93 (+0.98%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 11:50 AM | marketbeat.comGreat Lakes Advisors LLC Cuts Stock Holdings in Haemonetics Co. (NYSE:HAE)Great Lakes Advisors LLC trimmed its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 14.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 169,255 shares of the medical instruments suMay 18 at 10:20 AM | insidertrades.comHaemonetics Co. (NYSE:HAE) Insider Stewart W. Strong Sells 733 SharesMay 18 at 6:00 AM | marketbeat.comJump Financial LLC Acquires Shares of 12,066 Haemonetics Co. (NYSE:HAE)Jump Financial LLC bought a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 12,066 shares of the medical instruments supplier's stock, valued at approximately $1,032,000.May 17 at 7:57 PM | marketbeat.comStewart W. Strong Sells 733 Shares of Haemonetics Co. (NYSE:HAE) StockHaemonetics Co. (NYSE:HAE - Get Free Report) insider Stewart W. Strong sold 733 shares of the company's stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $96.04, for a total transaction of $70,397.32. Following the completion of the sale, the insider now directly owns 15,608 shares in the company, valued at $1,498,992.32. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.May 17 at 6:27 PM | markets.businessinsider.comHaemonetics Stock Up 10.9% YTD: Will the Rally Continue?May 15, 2024 | marketbeat.comBoston Partners Decreases Holdings in Haemonetics Co. (NYSE:HAE)Boston Partners lowered its position in Haemonetics Co. (NYSE:HAE - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 707,434 shares of the medical instruments supplier's stock aftMay 14, 2024 | marketbeat.comHeartland Advisors Inc. Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE)Heartland Advisors Inc. decreased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 13.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 221,697 shares of the medical instruments supplier's stock aMay 14, 2024 | markets.businessinsider.comHaemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial OptimismMay 14, 2024 | americanbankingnews.comJMP Securities Increases Haemonetics (NYSE:HAE) Price Target to $125.00May 14, 2024 | americanbankingnews.comBarrington Research Raises Haemonetics (NYSE:HAE) Price Target to $107.00May 14, 2024 | americanbankingnews.comHaemonetics (NYSE:HAE) Rating Reiterated by Needham & Company LLCMay 14, 2024 | americanbankingnews.comHaemonetics (NYSE:HAE) Hits New 12-Month High on Analyst UpgradeMay 13, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Reaches New 1-Year High on Analyst UpgradeHaemonetics (NYSE:HAE) Reaches New 12-Month High After Analyst UpgradeMay 13, 2024 | americanbankingnews.comQ1 2025 EPS Estimates for Haemonetics Co. (NYSE:HAE) Decreased by AnalystMay 13, 2024 | americanbankingnews.comHaemonetics Co. (NYSE:HAE) Receives $108.67 Average PT from AnalystsMay 10, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Given New $125.00 Price Target at JMP SecuritiesJMP Securities boosted their price target on shares of Haemonetics from $115.00 to $125.00 and gave the stock a "market outperform" rating in a report on Friday.May 10, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Average Rating of "Moderate Buy" from BrokeragesHaemonetics Co. (NYSE:HAE - Get Free Report) has earned an average rating of "Moderate Buy" from the four research firms that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and two have given a buy recommendationMay 10, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Announces Earnings ResultsHaemonetics (NYSE:HAE - Get Free Report) posted its earnings results on Thursday. The medical instruments supplier reported $0.90 EPS for the quarter, topping analysts' consensus estimates of $0.88 by $0.02. The company had revenue of $343.00 million for the quarter, compared to the consensus estimate of $329.53 million. Haemonetics had a return on equity of 22.37% and a net margin of 9.97%. The firm's revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 earnings per share.May 10, 2024 | finanznachrichten.deHaemonetics Corporation: Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations WebsiteMay 10, 2024 | markets.businessinsider.com4 Analysts Assess Haemonetics: What You Need To KnowMay 10, 2024 | finance.yahoo.comHaemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ...May 10, 2024 | markets.businessinsider.comStrong Buy: Haemonetics Corporation Set for Growth and Margin ExpansionMay 10, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Receives "Hold" Rating from Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Haemonetics in a research report on Friday.May 10, 2024 | americanbankingnews.comAnila Lingamneni Sells 2,305 Shares of Haemonetics Co. (NYSE:HAE) StockMay 10, 2024 | marketbeat.comVictory Capital Management Inc. Cuts Holdings in Haemonetics Co. (NYSE:HAE)Victory Capital Management Inc. lessened its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 42.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 207,341 shares of the medical instrumenMay 10, 2024 | americanbankingnews.comHaemonetics (NYSE:HAE) Stock Price Down 6.7% Following Insider SellingMay 9, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Stock Price Down 6.7% After Insider SellingHaemonetics (NYSE:HAE) Trading Down 6.7% Following Insider SellingMay 9, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Updates FY25 Earnings GuidanceHaemonetics (NYSE:HAE) updated its FY25 earnings guidance. The company provided EPS guidance of $4.45-$4.75 for the period, compared to the consensus estimate of $4.40. The company also issued revenue guidance of $1.37-$1.41 billionillion, compared to the consensus estimate of $1.37 billionillion.May 9, 2024 | insidertrades.comInsider Selling: Haemonetics Co. (NYSE:HAE) EVP Sells 2,305 Shares of StockMay 9, 2024 | markets.businessinsider.comHaemonetics Q4 Profit Falls, But Beats Estimates - UpdateMay 9, 2024 | msn.comHaemonetics Non-GAAP EPS of $0.90 beats by $0.01, revenue of $343.29M beats by $13.82MMay 9, 2024 | prnewswire.comHaemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations WebsiteMay 8, 2024 | finance.yahoo.comInsider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ...May 8, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) EVP Sells $218,975.00 in StockHaemonetics Co. (NYSE:HAE - Get Free Report) EVP Anila Lingamneni sold 2,305 shares of the stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $218,975.00. Following the completion of the sale, the executive vice president now owns 12,295 shares of the company's stock, valued at approximately $1,168,025. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.May 8, 2024 | markets.businessinsider.comHaemonetics is about to announce its earnings — here's what Wall Street expectsMay 7, 2024 | marketbeat.comLos Angeles Capital Management LLC Decreases Position in Haemonetics Co. (NYSE:HAE)Los Angeles Capital Management LLC reduced its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 51.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,638 shares of the medical instruments supplier's stock afteMay 6, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Sets New 12-Month High at $96.17Haemonetics (NYSE:HAE) Hits New 1-Year High at $96.17May 4, 2024 | marketbeat.comFisher Asset Management LLC Cuts Stock Position in Haemonetics Co. (NYSE:HAE)Fisher Asset Management LLC cut its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 17.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 711,436 shares of the medical inMay 2, 2024 | marketbeat.comAnalysts Set Expectations for Haemonetics Co.'s Q1 2025 Earnings (NYSE:HAE)Haemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research upped their Q1 2025 earnings per share estimates for Haemonetics in a note issued to investors on Tuesday, April 30th. Zacks Research analyst R. Department now expects that the medical instruments supplier will postApril 30, 2024 | markets.businessinsider.comMaintaining Buy Rating on Edwards Lifesciences Amid Mixed TAVR Performance and Strong TMTT GrowthApril 30, 2024 | marketbeat.comShort Interest in Haemonetics Co. (NYSE:HAE) Rises By 9.8%Haemonetics Co. (NYSE:HAE - Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 2,240,000 shares, a growth of 9.8% from the March 31st total of 2,040,000 shares. Based on an average daily trading volume, of 476,900 shares, the days-to-cover ratio is presently 4.7 days. Currently, 4.5% of the company's stock are sold short.April 29, 2024 | msn.com'Queen of Tears' shatters tvN drama viewership record with final episodeApril 29, 2024 | marketbeat.comCalifornia Public Employees Retirement System Has $19.64 Million Holdings in Haemonetics Co. (NYSE:HAE)California Public Employees Retirement System boosted its position in Haemonetics Co. (NYSE:HAE - Free Report) by 36.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 229,717 shares of the medical instruments supplier'sApril 23, 2024 | marketbeat.comLouisiana State Employees Retirement System Makes New Investment in Haemonetics Co. (NYSE:HAE)Louisiana State Employees Retirement System acquired a new position in Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 14,300 shares of the medical instrumenApril 21, 2024 | marketbeat.comKnights of Columbus Asset Advisors LLC Acquires 34,556 Shares of Haemonetics Co. (NYSE:HAE)Knights of Columbus Asset Advisors LLC lifted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 345.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,561 shares of tApril 18, 2024 | msn.comVivasure implants first venous patient in PerQseal device trialApril 17, 2024 | finance.yahoo.comIs Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?April 15, 2024 | marketbeat.comBrokers Offer Predictions for Haemonetics Co.'s FY2026 Earnings (NYSE:HAE)Haemonetics Co. (NYSE:HAE - Free Report) - Investment analysts at Barrington Research reduced their FY2026 EPS estimates for shares of Haemonetics in a research report issued to clients and investors on Friday, April 12th. Barrington Research analyst M. Petusky now forecasts that the medical instApril 10, 2024 | finance.yahoo.comHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024April 10, 2024 | prnewswire.comHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. HAE Media Mentions By Week HAE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼0.560.42▲Average Medical News Sentiment HAE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼196▲HAE Articles Average Week Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merit Medical Systems News ICU Medical News Glaukos News Axonics News iRhythm Technologies News PROCEPT BioRobotics News Tandem Diabetes Care News Globus Medical News Inari Medical News Inspire Medical Systems News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBill Gates is all about this tiny $2 stockTimothy SykesBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
